{"id":797742,"date":"2022-06-07T22:01:14","date_gmt":"2022-06-07T20:01:14","guid":{"rendered":"https:\/\/bebeez.it\/non-categorizzato\/orisdx-wins-665k-in-uchicagos-2022-new-venture-challenge-with-saliva-test-to-diagnose-oral-cancers\/"},"modified":"2023-07-11T10:43:30","modified_gmt":"2023-07-11T08:43:30","slug":"orisdx-wins-665k-in-uchicagos-2022-new-venture-challenge-with-saliva-test-to-diagnose-oral-cancers","status":"publish","type":"post","link":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/orisdx-wins-665k-in-uchicagos-2022-new-venture-challenge-with-saliva-test-to-diagnose-oral-cancers\/","title":{"rendered":"OrisDX Wins $665K in UChicago\u2019s 2022 New Venture Challenge with Saliva Test to Diagnose Oral Cancers"},"content":{"rendered":"CHICAGO--(BUSINESS WIRE)--#accelerator--A startup developing saliva-based diagnostics to screen for oral cancers and pre-cancers has won first place in the 26th Annual Edward L. Kaplan, \u201971, New Venture Challenge (NVC), the signature venture competition for MBA students at the University of Chicago Booth School of Business.\n\n\n\nMore than $1.76 million in investment was awarded to the 11 finalist teams competing in NVC finals Thursday, the largest amount ever awarded in the history of the pioneering startup accelerator. The event was held in person for the first time since 2019.\n\n\n\"Our finalist teams were spectacular and spectacularly diverse \u2014 from a test to detect cancer, to tiles for spacecraft, to a market for hydrogen, to wine and he
Abbonati<\/a> o Accedi<\/a> per leggere il resto di questo contenuto.<\/div><\/div>","protected":false},"excerpt":{"rendered":"

CHICAGO–(BUSINESS WIRE)–#accelerator–A startup developing saliva-based diagnostics to screen for oral cancers and pre-cancers has won first place in the 26th Annual Edward L. Kaplan, \u201971, New Venture Challenge (NVC), the signature venture competition for MBA students at the University of Chicago Booth School of Business. More than $1.76 million in investment was awarded to the […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[49625],"tags":[],"settori":[],"slider_categorie_and_home_page":[],"class_list":["post-797742","post","type-post","status-publish","format-standard","hentry","category-private-capital-in-north-america"],"acf":[],"yoast_head":"\nOrisDX Wins $665K in UChicago\u2019s 2022 New Venture Challenge with Saliva Test to Diagnose Oral Cancers - BeBeez<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/orisdx-wins-665k-in-uchicagos-2022-new-venture-challenge-with-saliva-test-to-diagnose-oral-cancers\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"OrisDX Wins $665K in UChicago\u2019s 2022 New Venture Challenge with Saliva Test to Diagnose Oral Cancers - BeBeez\" \/>\n<meta property=\"og:description\" content=\"CHICAGO--(BUSINESS WIRE)--#accelerator--A startup developing saliva-based diagnostics to screen for oral cancers and pre-cancers has won first place in the 26th Annual Edward L. Kaplan, \u201971, New Venture Challenge (NVC), the signature venture competition for MBA students at the University of Chicago Booth School of Business. More than $1.76 million in investment was awarded to the […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/orisdx-wins-665k-in-uchicagos-2022-new-venture-challenge-with-saliva-test-to-diagnose-oral-cancers\/\" \/>\n<meta property=\"og:site_name\" content=\"BeBeez\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-07T20:01:14+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-11T08:43:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"683\" \/>\n\t<meta property=\"og:image:height\" content=\"242\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"olomaster\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"olomaster\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/orisdx-wins-665k-in-uchicagos-2022-new-venture-challenge-with-saliva-test-to-diagnose-oral-cancers\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/orisdx-wins-665k-in-uchicagos-2022-new-venture-challenge-with-saliva-test-to-diagnose-oral-cancers\/\"},\"author\":{\"name\":\"olomaster\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/person\/f3523ef027b0af56aa28725439cc9518\"},\"headline\":\"OrisDX Wins $665K in UChicago\u2019s 2022 New Venture Challenge with Saliva Test to Diagnose Oral Cancers\",\"datePublished\":\"2022-06-07T20:01:14+00:00\",\"dateModified\":\"2023-07-11T08:43:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/orisdx-wins-665k-in-uchicagos-2022-new-venture-challenge-with-saliva-test-to-diagnose-oral-cancers\/\"},\"wordCount\":875,\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"articleSection\":[\"Private capital in North America\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/orisdx-wins-665k-in-uchicagos-2022-new-venture-challenge-with-saliva-test-to-diagnose-oral-cancers\/\",\"url\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/orisdx-wins-665k-in-uchicagos-2022-new-venture-challenge-with-saliva-test-to-diagnose-oral-cancers\/\",\"name\":\"OrisDX Wins $665K in UChicago\u2019s 2022 New Venture Challenge with Saliva Test to Diagnose Oral Cancers - BeBeez\",\"isPartOf\":{\"@id\":\"https:\/\/15.161.165.86\/#website\"},\"datePublished\":\"2022-06-07T20:01:14+00:00\",\"dateModified\":\"2023-07-11T08:43:30+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/orisdx-wins-665k-in-uchicagos-2022-new-venture-challenge-with-saliva-test-to-diagnose-oral-cancers\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/orisdx-wins-665k-in-uchicagos-2022-new-venture-challenge-with-saliva-test-to-diagnose-oral-cancers\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/orisdx-wins-665k-in-uchicagos-2022-new-venture-challenge-with-saliva-test-to-diagnose-oral-cancers\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/bebeez.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"OrisDX Wins $665K in UChicago\u2019s 2022 New Venture Challenge with Saliva Test to Diagnose Oral Cancers\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/15.161.165.86\/#website\",\"url\":\"https:\/\/15.161.165.86\/\",\"name\":\"BeBeez\",\"description\":\"BeBeez\",\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/15.161.165.86\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/15.161.165.86\/#organization\",\"name\":\"BeBeez\",\"url\":\"https:\/\/15.161.165.86\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"contentUrl\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"width\":309,\"height\":122,\"caption\":\"BeBeez\"},\"image\":{\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/person\/f3523ef027b0af56aa28725439cc9518\",\"name\":\"olomaster\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/f27d32333d7dec7da2843c6d51349029304daff2c6c3fb07164f8de234678661?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/f27d32333d7dec7da2843c6d51349029304daff2c6c3fb07164f8de234678661?s=96&d=mm&r=g\",\"caption\":\"olomaster\"},\"url\":\"https:\/\/bebeez.it\/en\/author\/olomaster\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"OrisDX Wins $665K in UChicago\u2019s 2022 New Venture Challenge with Saliva Test to Diagnose Oral Cancers - BeBeez","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/orisdx-wins-665k-in-uchicagos-2022-new-venture-challenge-with-saliva-test-to-diagnose-oral-cancers\/","og_locale":"en_US","og_type":"article","og_title":"OrisDX Wins $665K in UChicago\u2019s 2022 New Venture Challenge with Saliva Test to Diagnose Oral Cancers - BeBeez","og_description":"CHICAGO--(BUSINESS WIRE)--#accelerator--A startup developing saliva-based diagnostics to screen for oral cancers and pre-cancers has won first place in the 26th Annual Edward L. Kaplan, \u201971, New Venture Challenge (NVC), the signature venture competition for MBA students at the University of Chicago Booth School of Business. More than $1.76 million in investment was awarded to the […]","og_url":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/orisdx-wins-665k-in-uchicagos-2022-new-venture-challenge-with-saliva-test-to-diagnose-oral-cancers\/","og_site_name":"BeBeez","article_published_time":"2022-06-07T20:01:14+00:00","article_modified_time":"2023-07-11T08:43:30+00:00","og_image":[{"width":683,"height":242,"url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png","type":"image\/png"}],"author":"olomaster","twitter_card":"summary_large_image","twitter_misc":{"Written by":"olomaster","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/orisdx-wins-665k-in-uchicagos-2022-new-venture-challenge-with-saliva-test-to-diagnose-oral-cancers\/#article","isPartOf":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/orisdx-wins-665k-in-uchicagos-2022-new-venture-challenge-with-saliva-test-to-diagnose-oral-cancers\/"},"author":{"name":"olomaster","@id":"https:\/\/15.161.165.86\/#\/schema\/person\/f3523ef027b0af56aa28725439cc9518"},"headline":"OrisDX Wins $665K in UChicago\u2019s 2022 New Venture Challenge with Saliva Test to Diagnose Oral Cancers","datePublished":"2022-06-07T20:01:14+00:00","dateModified":"2023-07-11T08:43:30+00:00","mainEntityOfPage":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/orisdx-wins-665k-in-uchicagos-2022-new-venture-challenge-with-saliva-test-to-diagnose-oral-cancers\/"},"wordCount":875,"publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"articleSection":["Private capital in North America"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/orisdx-wins-665k-in-uchicagos-2022-new-venture-challenge-with-saliva-test-to-diagnose-oral-cancers\/","url":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/orisdx-wins-665k-in-uchicagos-2022-new-venture-challenge-with-saliva-test-to-diagnose-oral-cancers\/","name":"OrisDX Wins $665K in UChicago\u2019s 2022 New Venture Challenge with Saliva Test to Diagnose Oral Cancers - BeBeez","isPartOf":{"@id":"https:\/\/15.161.165.86\/#website"},"datePublished":"2022-06-07T20:01:14+00:00","dateModified":"2023-07-11T08:43:30+00:00","breadcrumb":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/orisdx-wins-665k-in-uchicagos-2022-new-venture-challenge-with-saliva-test-to-diagnose-oral-cancers\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bebeez.it\/en\/private-capital-in-north-america\/orisdx-wins-665k-in-uchicagos-2022-new-venture-challenge-with-saliva-test-to-diagnose-oral-cancers\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/orisdx-wins-665k-in-uchicagos-2022-new-venture-challenge-with-saliva-test-to-diagnose-oral-cancers\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bebeez.it\/en\/"},{"@type":"ListItem","position":2,"name":"OrisDX Wins $665K in UChicago\u2019s 2022 New Venture Challenge with Saliva Test to Diagnose Oral Cancers"}]},{"@type":"WebSite","@id":"https:\/\/15.161.165.86\/#website","url":"https:\/\/15.161.165.86\/","name":"BeBeez","description":"BeBeez","publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/15.161.165.86\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/15.161.165.86\/#organization","name":"BeBeez","url":"https:\/\/15.161.165.86\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/","url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","contentUrl":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","width":309,"height":122,"caption":"BeBeez"},"image":{"@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/15.161.165.86\/#\/schema\/person\/f3523ef027b0af56aa28725439cc9518","name":"olomaster","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/15.161.165.86\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/f27d32333d7dec7da2843c6d51349029304daff2c6c3fb07164f8de234678661?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f27d32333d7dec7da2843c6d51349029304daff2c6c3fb07164f8de234678661?s=96&d=mm&r=g","caption":"olomaster"},"url":"https:\/\/bebeez.it\/en\/author\/olomaster\/"}]}},"_links":{"self":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/797742","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/comments?post=797742"}],"version-history":[{"count":1,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/797742\/revisions"}],"predecessor-version":[{"id":891764,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/797742\/revisions\/891764"}],"wp:attachment":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/media?parent=797742"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/categories?post=797742"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/tags?post=797742"},{"taxonomy":"settori","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/settori?post=797742"},{"taxonomy":"slider_categorie_and_home_page","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/slider_categorie_and_home_page?post=797742"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}